Jazz Pharmaceuticals (JAZZ) Current Deferred Revenue (2010 - 2023)
Jazz Pharmaceuticals (JAZZ) posted quarterly Current Deferred Revenue of $4000.0 for Q3 2023, down 99.54% year-over-year from $871000.0 in Q3 2022, and little changed quarter-over-quarter from $4000.0 in Q2 2023.
Jazz Pharmaceuticals (JAZZ) Current Deferred Revenue (2010 - 2023) Analysis & Trends
Jazz Pharmaceuticals' Current Deferred Revenue history runs 14 years deep, the most recent figure standing at $4000.0 for Q3 2023.
- In Q3 2023, Current Deferred Revenue fell 99.54% year-over-year to $4000.0; the TTM figure through Sep 2023 stood at $4000.0 (down 99.54% YoY), while the FY2022 annual figure was $463000.0, down 81.89% from the prior year.
- Current Deferred Revenue for Q3 2023 stood at $4000.0, roughly flat from $4000.0 in the prior quarter.
- The five-year high for Current Deferred Revenue was $11.9 million in Q2 2019, with the low at $4000.0 in Q1 2023.
- The 5-year median for Current Deferred Revenue is $3.3 million (2021), against an average of $4.0 million.
- The sharpest annual moves came in 2019 and 2023: Current Deferred Revenue soared 84.96% in 2019, then slumped 99.76% in 2023.
- Jazz Pharmaceuticals' Current Deferred Revenue stood at $9.6 million in 2019, then tumbled by 49.26% to $4.9 million in 2020, then plunged by 47.42% to $2.6 million in 2021, then tumbled by 81.89% to $463000.0 in 2022, then slumped by 99.14% to $4000.0 in 2023.
- Business Quant data shows JAZZ's Current Deferred Revenue at $4000.0 in Q3 2023, $4000.0 in Q2 2023, and $4000.0 in Q1 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Jazz Pharmaceuticals | 15.90 Bn | 14.28 Bn | 1.09 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2023 | 4,000.00 |
| Jun 30, 2023 | 4,000.00 |
| Mar 31, 2023 | 4,000.00 |
| Dec 31, 2022 | 463,000.00 |
| Sep 30, 2022 | 871,000.00 |
| Jun 30, 2022 | 1.28 Mn |
| Mar 31, 2022 | 1.69 Mn |
| Dec 31, 2021 | 2.56 Mn |
| Sep 30, 2021 | 3.25 Mn |
| Jun 30, 2021 | 2.44 Mn |
| Mar 31, 2021 | 4.23 Mn |
| Dec 31, 2020 | 4.86 Mn |
| Sep 30, 2020 | 6.04 Mn |
| Jun 30, 2020 | 3.63 Mn |
| Mar 31, 2020 | 8.40 Mn |
| Dec 31, 2019 | 9.58 Mn |
| Sep 30, 2019 | 10.76 Mn |
| Jun 30, 2019 | 11.94 Mn |
| Mar 31, 2019 | 4.72 Mn |
| Dec 31, 2018 | 5.41 Mn |